Abstract Body

Background: Cell activation via T-cell receptor (TCR) stimulation represents a standard step in the analysis of primary cell models of HIV latency. Reactivation from latency using other pharmacological or immunological stimuli is generally benchmarked against the results of TCR signaling. We analyzed the molecular interaction between TCR stimulation and SAHA (a histone deacetylase inhibitor that increases viral transcription) to assess whether these two approaches were synergistic or antagonistic at the molecular level – with the goal of understanding post-transcriptional processing of viral transcripts. Methodology: We use a CD4+ TCM latency model (Sahu et al. 2006, Tyagi et al. 2010) that requires sorting of activated and infected cells, followed by reversion to a resting memory phenotype and maintenance of latent cells by co-culture with H80 feeder cells. After 4 weeks of latency, cells were reactivated with anti-CD3/anti-CD28/IL-2 (TCR stimulation), SAHA, or both. Materials were collected at 8h and 24h post-stimulation for viral reporter analysis by FACS and for RNA-seq analysis. RNA data were normalized by added spike-ins, and results are reported under 5% false discovery rate. Results: In this primary cell model, SAHA was characterized by an increase in viral transcripts at both 8h and 24h post-treatment as compared to DMSO, while increase in viral transcripts upon TCR stimulation was observed mostly at 24 h. Enhancement of virally-encoded GFP translation was observed mainly upon TCR stimulation, regardless of SAHA adjunction. Analysis of variance on transcriptome profiles performed over 14,036 genes revealed that TCR stimulation altered the expression of 8384 genes, enriched for cell metabolism and cell cycle among other pathways, and consistent with the induction of a cellular environment supportive of viral replication. Addition of SAHA dampened the transcriptional response to TCR stimulation: the two responses were anti-correlated (r=-0.19, p<10-109). In particular, a fraction of TCR regulated genes (n=1064, 13%) showed a significant non-additive response upon SAHA co-administration, which was highly dominated by antagonistic effects (n=953, 90%), suggesting a negative interaction between the two treatments. Conclusions: The current data suggest that activation of cells treated with SAHA does not improve translation of viral transcripts beyond effects from cellular activation alone. On the contrary, transcriptome analysis indicates that SAHA antagonizes the expression of numerous genes that depend on TCR signaling.